Microbial Genomics: Tropical Treasure?  by Stephens, Craig
Microbial Genomics: Tropical
Treasure?
Craig Stephens
A Brazilian consortium has unveiled the genomic DNA
sequence of the purple-pigmented bacterium Chro-
mobacterium violaceum, a dominant component of
the tropical soil microbiota. The sequence provides
insight into the abundant potential of this organism
for biotechnological and pharmaceutical applications.
Exploring global biodiversity is a major focus of
contemporary biological research, and documenting the
extraordinary richness of tropical habitats is a priority.
Although microbial diversity is seldom considered in this
regard, it could turn out to be of great value to develop-
ing nations. New work from the Brazilian National
Genome Project Consortium [1] examines the genome
of a fascinating bacterium, Chromobacterium vio-
laceum, a major component of tropical soil microbiota.
Analysis of the C. violaceum genome provides impor-
tant clues about its physiological adaptation to tropical
soils and aquatic habitats, its capacities as an oppor-
tunistic pathogen, and its potential biotechnological and
pharmaceutical applications.  
The Brazilian National Genome Project Consortium,
BRGene, is a model for genomics research in the devel-
oping world [2]. BRGene evolved as an umbrella orga-
nization building on the success of the Organization for
Nucleotide Sequencing and Analysis, ONSA, a collabo-
rative genomics research network based in the state of
Sao Paulo. (The acronym ‘ONSA’ alludes to the Por-
tuguese word for jaguar, ‘onça’, a playful allusion to The
Institute for Genomic Research, ‘TIGR’, a major force in
genomics research in the US.) ONSA and BRGene are
‘virtual institutes’ composed of numerous laboratories
at Brazilian universities and research centers, each con-
tributing sequence data to coordinated projects. This
distributed strategy avoids concentrating investment in
large sequencing centers; rather, it develops expertise
and spreads critical equipment and funding among
existing institutions, enhancing their capabilities and
engendering communication and cooperation. 
Brazilian genomics efforts have focused on projects
with national relevance [2]. Expertise in bacterial
genomics was developed early on with successful
efforts to analyze the genomes of three agronomically
significant pathogens: Xylella fastidiosa, the cause of
Pierce’s disease in grapes and variegated chlorosis in
citrus crops [3], and Xanthomonas campestris and Xan-
thomonas citri, which cause canker in citrus trees [4].
Brazilian projects are not limited to microbes, of course;
other efforts include analysis of sugar cane, coffee, and
cancer-related genes in humans [5].
The Chromobacterium violaceum genome project is
perhaps one of the more speculative Brazilian genome
efforts. The organism is not harmful to plants, and is only
a rare, opportunistic (but potentially lethal) pathogen of
animals and humans. It is, however, a major component
of the tropical soil microbiota [6], and highly abundant in
the Rio Negro [1]. The most striking feature of C. vio-
laceum is its profuse production of a purple pigment
called violacein, derived from tryptophan [7] (Figure 1).
Like many soil microbes, C. violaceum excretes ‘sec-
ondary metabolites’ — including violacein — as
weapons against competitors and/or predators [6,8].
Secondary metabolites have an honored place in
microbiology, starting with Fleming’s observation of the
effects of penicillin on Staphylococci. Since then, micro-
biologists have identified a treasure trove of excreted
compounds, including an enormously valuable range of
antibiotics and medicinal compounds. With so much
microbial diversity awaiting exploration, we obviously
have not exhausted nature’s stock. Violacein may be
poised for a spot in the pantheon of high-value microbial
products. It has bacteriocidal activity against Mycobac-
terium tuberculosis, and pronounced anti-protozoal
activity against organisms such as Trypanosoma cruzi
(the cause of Chagas disease) and Leishmania species
(agents of leishmaniasis) [9]. Possible antiviral and anti-
cancer activities are being investigated as well [10].
The C. violaceum genome is nearly 5 megabases,
encoding just over 4400 genes. Overall, the genome is
most similar to that of Ralstonia solanacearum, a soil-
borne phytopathogen. Surprisingly, nearly 10% of the C.
violaceum genes are most closely related to those of
Pseudomonas aeruginosa, another common soil
microbe and a highly virulent opportunistic pathogen,
but one which is considerably more distantly related to
C. violaceum on the basis of ribosomal RNA sequence
criteria. The similar habitats occupied by these microbes
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Figure 1. Chromobacterium violaceum colonies showing
purple pigmentation due to violacein production. 
The inset shows the chemical structure of violacein [6]. (Photo
courtesy Daryn Baker, Santa Clara University.)
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has undoubtedly steered their genomic content in com-
parable directions; to what extent lateral gene transfer
between C. violaceum and pseudomonads in the
crowded soil microcosm accounts for the similarity
between these species has not been fully examined. 
Like the genomes of R. solanacearum and P. aerugi-
nosa, that of C. violaceum encodes a specialized, ‘Type
III’ protein secretion system; but unlike those more
accomplished pathogens, C. violaceum seems to be
missing the arsenal of secreted ‘effector’ proteins
employed to compromise host cells during infection
[11]. Their absence might explain the rather poor ability
of C. violaceum to infect humans, and its apparent
harmlessness to plants. On the other hand, the C. vio-
laceum genome does encode a number of gene prod-
ucts that potentially allow it to damage mammalian
hosts, including several hemolysin-like proteins.
As might be expected for a free-living soil microbe, the
C. violaceum genome evinces a robust and flexible phys-
iology, capable of acquiring diverse nutrients through
dozens of transport systems, and utilizing a variety of
substrates and electron acceptors for aerobic or anaer-
obic growth. The ability of this organism to interpret and
respond to complex and dynamic habitats depends on
an enormous array of sensors and signaling pathways.
Prominent among these is the chemotaxis system that
guides flagellum-based movement toward nutrients and
away from noxious compounds. Indeed, 41 distinct
membrane-bound sensors for guiding chemotaxis —
methyl-accepting chemotaxis proteins — are encoded in
the C. violaceum genome, the largest number observed
in a single prokaryotic genome to date. Environmentally
responsive motility would thus seem to be a major adap-
tive feature for this microbe. 
Violacein production is controlled by ‘quorum
sensing’, a regulatory mechanism that restricts activity
to conditions of high cell density. Quorum sensing
evolved to control processes that are presumably
beneficial when a particular organism is highly
concentrated, such as bioluminesence by symbiotic
bacteria inhabiting light organs of fish or squid.
Quorum-sensing bacteria constitutively produce a
diffusible signal molecule, an N-acylhomoserine
lactone (AHL) [12]. When enough cells are crowded
together, AHL concentrations build up to a threshold
level that activates a cognate transcription factor,
which then turns on expression of target genes. 
In C. violaceum, many other gene products, in
addition to the enzymes for violacein production, may
be under quorum-sensing control, including enzymes
for cyanide production, production of the antibiotic
phenazine, and secreted hydrolytic enzymes for
extracellular polymer degradation. Because violacein is
so easily detected by its purple color, and quantified,
violacein production by C. violaceum has been devel-
oped as a simple bioassay for AHL production by other
bacteria [13]. Whether the potential to respond to
‘foreign’ AHLs is biologically significant to C. violaceum
in natural habitats is an intriguing question for the future. 
Aside from the potential medical utility of violacein, C.
violaceum could have other practical applications. For
example, the ability of this organism to synthesize poly-
hydroxyalkanoate polymers suggests it could be useful
in production of biodegradable plastics, a field of much
current interest [14,15]. The C. violaceum genome
sequence also revealed an acid dehalogenase, opening
a door to potential applications in bioremediation, such
as detoxification of chlorinated compounds that conta-
minate soils at industrial sites [16]. On perhaps a less
environmentally friendly note, Campbell et al. [17] have
shown that cyanide produced by C. violaceum cultures
can be used to enhance gold recovery from ore. They
proposed that on-site generation of cyanide by C.
violaceum at remote gold mining facilities could be a
practical strategy for enhancing gold production. The
newly revealed genome sequence offers tantalizing
clues to capabilities of this organism that are simply
begging for experimental investigation. The competed
C. violaceum genome sequence should also facilitate
its genetic manipulation to further enhance valuable
traits. If these efforts pan out, Brazilian scientists might
truly strike gold with this microbe. 
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